Congregational birth certificate of Jacques Judah Lyons

Digital image

Copy of birth certificate of Jacques Judah Lyons

Digital image

Acknowledgement of Jacques Judah Lyons' letter by Sir Moses Montefiore

Digital image

Draft of letter by Jacques Judah Lyons to Sir Moses Montefiore, sending him payment for the Jews of Palestine, and acknowledgement

Digital image

Copy of letter from Jacques Judah Lyons to Sir Moses Montefiore enclosing bill of exchange for Palestinian Jews

Digital image

Lecture by Jacques Judah Lyons on the history of the Jews, given before the Hebrew Religious and Literary Library Association

Digital image

Sermon by Jacques Judah Lyons on the death of President William Henry Harrison

Digital image

Book of Selichot by Jacques Judah Lyons written in Surinam

Digital image

Letter to Jacques Judah Lyons and notes on Hebrew grammar by Joshua Seixas

Digital image

Various letters to Jacques Judah Lyons

Digital image

El Musteriense de la cueva de Harregi en Aussurucq, Soule (Excavaciones: Pierre Roucher, 1954-1960)

[ES] La cueva de Harregi (Aussurucq, Pays de Soule), excavada por P. Boucher entre 1954 y 1960, contiene testimonios prehistóricos del Paleolítico medio, superior y Postpaleolítico. En este artículo se analizan las evidencias de fauna e industria lítica asimiladas al Paleolítico medio. Importantes alteraciones estratigráficas postdeposicionales modificaron la original posición topográfica de la mayor parte de los depósitos musterienses. La composición global del lote industrial y de la serie faunística recuerdan intensamente a los controlados en los niveles musterienses Cj y Cjr de la muy cercana cueva de Gatzarria. Ello hace, bien plantear la posibilidad de una antigua organización estratigráfica y arqueológica de los depósitos musterienses como la de Gatzarria, lamentablemente perturbada por serios procesos hídricos erosivos, bien contemplar el hecho de una secuencia diferente, propia y, en cierta forma, contradictoria con la dinámica reconocida en Gatzarria.

Atelier ORIXAS: Projeto Tripartite África/Brasil/França: luta contra a desertificação: promoção da segurança alimentar e redução da pobreza.

No âmbito do Programa de Cooperação Científica Tripartite entre a Agence Inter-établissements de Recherche pourle Développement (AIRD), Agence Panafricaine de la Grande Muraille Verte (APGMV) e o Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), o projeto ORIXAS "Observatórios Regionais Integrados de Regiões Árida, Semiáridas e Sub-úmidas secas" concebido em uma visão transversal, foca principalmente em metodologias e ferramentas para apoiar dispositivos de monitoramento ambiental para ser aplicado nos países inseridos na iniciativa africana Grande Muralha Verde - GMV (Burkina-Faso, Djibouti, Érythrée, Éthiopie, Mali, Mauritanie, Niger, Nigeria, Sénégal, Soudan, Tchad) e tem como objetivo desenvolver abordagens metodológicas e produtos compartilhados para melhorar a avaliação e monitoramento da desertificação e os impactos diretos ou indiretos de iniciativas para lutar contra o desmatamento e desertificação no âmbito da GMV. Esta publicação contempla aspectos metodológicos utilizados pelo projeto "ORIXAS" durante a primeira oficina de trabalho coletivo África-Brasil-França - Atelier (MAISON DE LA TÉLÉDÉTECTION), realizada de 10 a 19 de junho de 2014, em Montpellier França, objetivando informar a forma de execução dos estudos que vêm sendo realizados no escopo do projeto, visando principalmente a luta contra a desertificação, promoção da segurança alimentar e redução da pobreza nos países inseridos na iniciativa africana Grande Muralha Verde - GMV.

Western missions and missionaries : a series of letters / by P.J. de Smet.

http://www.archive.org/details/westernmissionsa00smetrich

Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.

BACKGROUND & AIMS: Prophylactic administration of interleukin (IL)-10 decreases the severity of experimental pancreatitis. Prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in humans is a unique model to study the potential role of IL-10 in this setting. METHODS: In a single-center, double-blind, randomized, placebo-controlled study, the effect of a single injection of 4 microg/kg (group 1) or 20 microg/kg (group 2) IL-10 was compared with that of placebo (group 0), all administered 30 minutes before therapeutic ERCP. The primary endpoint was the effect of IL-10 on serum levels of amylases and lipases measured 4, 24, and 48 hours after ERCP. The secondary objective was to evaluate changes in plasma cytokines (IL-6, IL-8, tumor necrosis factor) at the same time points and the incidence of acute pancreatitis in the 3 groups. Subjects undergoing a first therapeutic ERCP were eligible for inclusion. RESULTS: A total of 144 patients were included. Seven were excluded based on intention to treat (n = 1) or per protocol (n = 6). Forty-five, 48, and 44 patients remained in groups 0, 1, and 2, respectively. The 3 groups were comparable for age, sex, underlying disease, indication for treatment, type of treatment, and plasma levels of C-reactive protein (CRP), cytokines, and hydrolases at baseline. No significant difference was observed in CRP, cytokine, and hydrolase plasma levels after ERCP. Forty-three patients developed hyperhydrolasemia (18 in group 0, 14 in group 1, and 11 in group 2; P = 0.297), and 19 patients developed acute clinical pancreatitis (11 in group 0, 5 in group 1, 3 in group 2; P = 0.038). Two severe cases were observed in the placebo group. No mortality related to ERCP was observed. Logistic regression identified 3 independent risk factors for post-therapeutic ERCP pancreatitis: IL-10 administration (odds ratio [OR], 0.46; 95% confidence interval [95% CI], 0.22-0.96; P = 0.039), pancreatic sphincterotomy (OR, 5.04; 95% CI, 1.53-16.61; P = 0.008), and acinarization (OR, 8.19; 95% CI, 1.83-36.57; P = 0.006). CONCLUSIONS: A single intravenous dose of IL-10, given 30 minutes before the start of the procedure, independently reduces the incidence of post-therapeutic ERCP pancreatitis.